CLINICAL_TRIALS
trial_result
· 2021-04-19
Clinical Trial Update: Riluzole in Spinal Cord Injury Study [Phase 2, Phase 3]
Summary
Clinical trial update for riluzole in spinal cord injury shows Phase 2 and Phase 3 studies terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AOSpine North America Research Network | Conditions: Spinal Cord Injury | Phase 2, Phase 3 | Status: TERMINATED